Overview

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the number of participants with reversible pulmonary hypertension (vasoreactivity) due to nitric oxide for inhalation and oxygen as compared to 100% oxygen.
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Nitric Oxide
Vasodilator Agents